Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
How can I begin treatment
Some peptide-related medications have approval for specific medical conditions
The SURMOUNT-1 clinical trial assessed the safety of Tirzepatide in adults with obesity or who were overweight but did not have diabetes
Who its for May be a fit if you Are exploring provider-guided weight management Are navigating weight changes in perimenopause or menopause Prefer a once-weekly injection Want licensed provider oversight and ongoing support Not appropriate if you Have a personal or family history of medullary thyroid carcinoma or MEN 2 Are pregnant, trying to conceive, or breastfeeding Have a history of pancreatitis or certain GI conditions (discuss with your provider) Are advised against GLP-1 care by your provider Eligibility is always determined by a licensed provider after reviewing your intake
US$ 21.46
US$ 27.27
US$ 24.62
US$ 20.02
US$ 23.33
US$ 23.81
US$ 21.84
